Cite
HARVARD Citation
Price, T. et al. (n.d.). Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab1. Cancer medicine. pp. 277-285. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Price, T. et al. (n.d.). Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab1. Cancer medicine. pp. 277-285. [Online].